2022 annual financial data
Voyager Therapeutics 2022 Operating margin
Voyager Therapeutics 2022 operating margin with verified reported values.
Direct answer
Operating margin was -124.27%.
Operating income was -50,837,000 USD and net income was -46,408,000 USD.
Operating cash flow was -12,509,000 USD.
Get free Voyager Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 40,907,000 USD
- Operating income
- -50,837,000 USD
- Net income
- -46,408,000 USD
- Operating cash flow
- -12,509,000 USD